Filing Details
- Accession Number:
- 0001576427-23-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-08 16:17:05
- Reporting Period:
- 2023-03-06
- Accepted Time:
- 2023-03-08 16:17:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576427 | Criteo S.a. | CRTO | Services-Advertising Agencies (7311) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711277 | Nathalie Balla | C/O Criteo Legal Dept. 387 Park Avenue South, 12Th Floor New York NY 10016 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2023-03-06 | 2,600 | $20.90 | 20,400 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-03-06 | 2,600 | $32.67 | 17,800 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2023-03-06 | 22,400 | $20.90 | 40,200 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-03-06 | 22,400 | $32.36 | 17,800 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2023-03-06 | 12,177 | $18.49 | 29,977 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-03-06 | 12,177 | $32.36 | 17,800 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2023-03-07 | 4,846 | $18.62 | 22,646 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2023-03-07 | 4,846 | $32.03 | 17,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non-employee Warrant (right to buy) | Disposition | 2023-03-06 | 2,600 | $0.00 | 2,600 | $20.90 |
| Ordinary Shares | Non-employee Warrant (right to buy) | Disposition | 2023-03-06 | 22,400 | $0.00 | 22,400 | $20.90 |
| Ordinary Shares | Non-employee Warrant (right to buy) | Disposition | 2023-03-06 | 12,177 | $0.00 | 12,177 | $18.49 |
| Ordinary Shares | Non-employee Warrant (right to buy) | Disposition | 2023-03-07 | 4,846 | $0.00 | 4,846 | $18.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,400 | 2028-10-25 | No | 4 | M | Direct | |
| 0 | 2028-10-25 | No | 4 | M | Direct | |
| 14,243 | 2029-10-24 | No | 4 | M | Direct | |
| 9,397 | 2029-10-24 | No | 4 | M | Direct |
Footnotes
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431).
- For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.51 to $32.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $ 32.845 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.49 using the exchange rate as of March 6, 2023 (1.00 = $ 0.9431).
- The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.62 using the exchange rate as of March 7, 2023 (1.00 = $ 0.9366).
- The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Warrant granted on October 25, 2018. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 25, 2028.
- Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029.
Billionaire Hedge Funds
